Abnormalities of serum and plasma components in patients with multiple sclerosis
- PMID: 3886192
- PMCID: PMC7130298
- DOI: 10.1016/s0009-9120(85)80016-3
Abnormalities of serum and plasma components in patients with multiple sclerosis
Abstract
Qualitative and quantitative abnormalities in protein and non-protein components of serum and plasma in patients with multiple sclerosis have been the subjects of numerous reports. In this review many of the more recent observations are documented and evaluated. It is concluded that at present the welter of information that has been gathered does not contribute in any major, coherent way to our understanding of the etiology or pathogenesis of the disorder. Several of the abnormalities that have been observed may be future candidates for biochemical markers for multiple sclerosis; at present none is sufficiently reliable, distinctive or easily performed to warrant the status of a useful diagnostic or prognostic test.
References
-
- Iivanainen MV. The significance of abnormal immune responses in patients with multiple sclerosis. J Neuroimmunol. 1981;1:141–172. - PubMed
-
- Rathke E, Jones M. Serum cerebrosides in multiple sclerosis. J Neurochem. 1974;22:311–313. - PubMed
-
- Samuelson K. Separation and identification of cerebrosides in cerebrospinal fluid by gas chromatography—mass spectrometry. Scand J Clin Lab Invest. 1971;27:381–391. - PubMed
-
- Tourtellotte WW, Haerer AF. Lipids in cerebrospinal fluid. XII. In multiple sclerosis and retrobulbar neuritis. Arch Neurol. 1969;20:605–615. - PubMed
-
- Vincent B, Jones M. Plasma cerebrosides in stroke and multiple sclerosis. Ann Clin Lab Sci. 1975;5:45–51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical